Sedana Medical AB (publ) (STO:SEDANA)
Sweden
· Delayed Price · Currency is SEK 17.84
-0.28 (-1.55%)
Feb 21, 2025, 5:29 PM CET
Sedana Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 178.75 | 153.87 | 122.87 | 159.15 | 141.77 | Upgrade
|
| Revenue Growth (YoY) | 16.17% | 25.23% | -22.80% | 12.26% | 97.88% | Upgrade
|
| Cost of Revenue | 52.61 | 44.89 | 36.79 | 52.45 | 52.87 | Upgrade
|
| Gross Profit | 126.14 | 108.98 | 86.07 | 106.71 | 88.9 | Upgrade
|
| Selling, General & Admin | 156.6 | 154.74 | 169.94 | 148.31 | 102.42 | Upgrade
|
| Research & Development | 20.29 | 20.81 | 19.94 | 19.7 | 7.86 | Upgrade
|
| Other Operating Expenses | 0.02 | -0.02 | 0.12 | -0.11 | -0.02 | Upgrade
|
| Operating Expenses | 176.91 | 175.53 | 190.01 | 167.9 | 110.26 | Upgrade
|
| Operating Income | -50.77 | -66.55 | -103.93 | -61.2 | -21.36 | Upgrade
|
| Interest Expense | - | -0.22 | -0.26 | -0.24 | -0.19 | Upgrade
|
| Interest & Investment Income | 16.31 | 15.17 | 3.58 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 24.51 | -7.42 | 27.68 | 4.07 | -2.56 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | - | -0 | Upgrade
|
| Pretax Income | -9.95 | -59.02 | -72.93 | -57.37 | -24.1 | Upgrade
|
| Income Tax Expense | 0.73 | 0.59 | 0.57 | 0.6 | 3.04 | Upgrade
|
| Net Income | -10.67 | -59.61 | -73.51 | -57.97 | -27.14 | Upgrade
|
| Net Income to Common | -10.67 | -59.61 | -73.51 | -57.97 | -27.14 | Upgrade
|
| Shares Outstanding (Basic) | 99 | 99 | 99 | 93 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 99 | 99 | 99 | 93 | 92 | Upgrade
|
| Shares Change (YoY) | - | - | 6.85% | 1.54% | 9.27% | Upgrade
|
| EPS (Basic) | -0.11 | -0.60 | -0.74 | -0.62 | -0.30 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.60 | -0.74 | -0.62 | -0.30 | Upgrade
|
| Free Cash Flow | -38.96 | -38.58 | -116.17 | -46.41 | -20.29 | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -0.39 | -1.17 | -0.50 | -0.22 | Upgrade
|
| Gross Margin | 70.57% | 70.83% | 70.06% | 67.05% | 62.71% | Upgrade
|
| Operating Margin | -28.40% | -43.25% | -84.59% | -38.45% | -15.07% | Upgrade
|
| Profit Margin | -5.97% | -38.74% | -59.83% | -36.42% | -19.14% | Upgrade
|
| Free Cash Flow Margin | -21.80% | -25.07% | -94.55% | -29.16% | -14.31% | Upgrade
|
| EBITDA | -29.17 | -64.19 | -100.56 | -56.8 | -16.92 | Upgrade
|
| EBITDA Margin | -16.32% | -41.72% | -81.85% | -35.69% | -11.93% | Upgrade
|
| D&A For EBITDA | 21.6 | 2.36 | 3.38 | 4.4 | 4.44 | Upgrade
|
| EBIT | -50.77 | -66.55 | -103.93 | -61.2 | -21.36 | Upgrade
|
| EBIT Margin | -28.40% | -43.25% | -84.59% | -38.45% | -15.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.